About Asterism Pharmaceuticals Private Limited
Data last updated:
Asterism Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51900DL2016PTC298664. Its GSTIN is 07AAOCA3277G1ZH (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pooja Singh and Rajesh Ranjan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 99 Second Floor Dda Shed Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.07 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹1.74 Lakh (net margin 1.6%) and EBITDA of ₹3.05 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asterismpharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressA 99 Second Floor Dda Shed Okhla Industrial Area Phase – 2, New Delhi, Delhi, India – 110020
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Asterism Pharmaceuticals Private Limited
The main business activity of Asterism Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Asterism Pharmaceuticals Private Limited FY 2025 filings available
Asterism Pharmaceuticals Private Limited reported revenue of ₹1.07 Cr (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Asterism Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 29% growth in the latest year. EBITDA rose 322% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Asterism Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.05 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Asterism Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Asterism Pharmaceuticals are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Macwin Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | 5.0% | •••• | Chandigarh, India |
| Wyton Pharmaceuticals & Agrotech Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | 248.0% | •••• | Lucknow, Uttar Pradesh, India |
| Medswap Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Kolhapur, Maharashtra, India |
| Insutik Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Bareilly, Uttar Pradesh, India |
| Health Essentials (India) Private Limited | ₹1.07 Cr (FY 2020) | •••• | •••• | -44.0% | •••• | Hyderabad, Telangana, India |
| Asterism Pharmaceuticals Private Limited this company | ₹1.07 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | New Delhi, Delhi, India |
| Neolife Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2023) | •••• | •••• | 57.0% | •••• | Nagole, Hyderabad, Telangana, India |
| Pharmaco Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | 36.0% | •••• | New Delhi, Delhi, India |
| Oswald Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | 80.0% | •••• | Bangalore, Karnataka, India |
| Faith-Build Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -23.0% | •••• | Aurangabad, Maharashtra, India |
| Exact Medcare Private Limited | ₹1.07 Cr (FY 2025) | •••• | •••• | -26.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Asterism Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals Private Limited is audited by DBJ & ASSOCIATES for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| DBJ & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Singh | Director | 31 Aug 2022 | 4 Years 1 Months | Current |
| Rajesh Ranjan | Director | 28 Apr 2016 | 10 Years 5 Months | Current |
Ownership and Shareholding of Asterism Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, West, Delhi | Civil suit | Filed against the company by Foregen Healthcare Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Bal Govind Tiwari ceased to be Director on 31 Dec 2022.
Credit Ratings, Litigation & Regulatory Alerts for Asterism Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Asterism Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Asterism Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOCA3277G1ZH | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Asterism Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asterism Pharmaceuticals Private Limited
Asterism Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 April 2016 (10+ years old) and is registered under CIN U51900DL2016PTC298664.
Asterism Pharmaceuticals reported revenue of ₹1.07 Cr for FY 2025 (up 29% YoY).
Asterism Pharmaceuticals has 2 current directors:
- Pooja Singh - Director
- Rajesh Ranjan - Director
Asterism Pharmaceuticals reported a net profit of ₹1.74 Lakh (net margin 1.6%) and EBITDA of ₹3.05 Lakh (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Asterism Pharmaceuticals is 12% over three years. In the latest year (FY 2025) revenue rose 29%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Asterism Pharmaceuticals is 07AAOCA3277G1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Asterism Pharmaceuticals is U51900DL2016PTC298664. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Asterism Pharmaceuticals has 1 court case on record: 1 filed against it.
Asterism Pharmaceuticals was incorporated on 28 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Asterism Pharmaceuticals by revenue are Macwin Pharmaceuticals Private Limited, Wyton Pharmaceuticals & Agrotech Private Limited, Medswap Pharmaceuticals Private Limited, Insutik Pharmaceuticals Private Limited, Health Essentials (India) Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Bal Govind Tiwari ceased to be Director on 31 Dec 2022. Pooja Singh was appointed as Director on 31 Aug 2022. Sanjay Kumar Chawala ceased to be Director on 07 May 2020. Asterism Pharmaceuticals has 5 board changes on record in total.